Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Accounts Payable & Accrued Expense : ¥3,150 Mil (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Tianjin Pharmaceutical Da Ren Tang Group Accounts Payable & Accrued Expense?

Tianjin Pharmaceutical Da Ren Tang Group's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥2,748 Mil) to Dec. 2023 (¥2,974 Mil) and increased from Dec. 2023 (¥2,974 Mil) to Mar. 2024 (¥3,150 Mil).

Tianjin Pharmaceutical Da Ren Tang Group's annual accounts payable & accrued expense increased from Dec. 2021 (¥2,187 Mil) to Dec. 2022 (¥3,008 Mil) but then declined from Dec. 2022 (¥3,008 Mil) to Dec. 2023 (¥2,974 Mil).

Tianjin Pharmaceutical Da Ren Tang Group Accounts Payable & Accrued Expense Historical Data

The historical data trend for Tianjin Pharmaceutical Da Ren Tang Group's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Pharmaceutical Da Ren Tang Group Accounts Payable & Accrued Expense Chart

Tianjin Pharmaceutical Da Ren Tang Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

1,791.95

1,916.18

2,186.70

3,008.45

2,974.00

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															3,080.07	2,929.61	2,747.61	2,974.00	3,150.02

Tianjin Pharmaceutical Da Ren Tang Group Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (SHSE:600329) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

T14:Singapore

Address

No. 17 Baidi Road, Zhong Xin Mansion, Nankai District, Tianjin, CHN, 300193

Website

http://www.jydrt.com.cn

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Headlines

No Headlines